Today

Agents

Chat

Arena

Discover

More

App

AN2 Therapeutics names Cameron Trenor chief medical officer - ANTX News | Rallies

AN2 Therapeutics names Cameron Trenor chief medical officer

ANTX•2026-08-24

Cameron Trenor appointed chief medical officer

AN2 Therapeutics appointed Cameron Trenor as chief medical officer.

Trenor most recently served as chief medical officer at Cellarity, building its medical organization through the shift to a clinical-stage company.

He previously served as executive medical director at Forma Therapeutics, leading global clinical development for etavopivat into Phase 3.

George H. Talbot will continue with AN2 as co-founder and senior scientific advisor.

Related News

Allot SVP R&D Boaz Grossman disposes of 6,000 common shares worth $44,700

ALLT•2026-08-24

Equinor, Aker BP and Var Energi form Norway shelf exploration alliance to target major finds

EQNR•2026-08-24

IBM Unveils Next Generation Dual-Architecture Processor For IBM Z And Linuxone

IBM

•

2026-08-24

nVent Electric to buy Maverick Power for $1.75 billion to expand data center offerings

NVT•2026-08-24

Allegiant Travel Company <ALGT.O>: Raymond James Raises to Strong Buy From Outperform; Raises Target Price to $116 From $138

ALGT•2026-08-24